FDA Issues Warning Letter to Purushothaman Damodara Kumaran, M.D.
January 14, 2026
January 14, 2026
WASHINGTON, Jan. 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Purushothaman Damodara Kumaran, M.D. from the Center for Drug Evaluation and Research:
* * *
Recipient: Purushothaman Damodara Kumaran, M.D., Senthil Specialty Hospital, Number 10 and 12, Thillai Maistry Street, Pondicherry 605001 Puducherry, India
Issuing Office: Center for Drug Evaluation and Research (CDER), United S . . .
* * *
Recipient: Purushothaman Damodara Kumaran, M.D., Senthil Specialty Hospital, Number 10 and 12, Thillai Maistry Street, Pondicherry 605001 Puducherry, India
Issuing Office: Center for Drug Evaluation and Research (CDER), United S . . .